Global Injectable Drug Delivery Devices Market to grow at a CAGR of 11.26% by 2030, Evaluates DelveInsight

According to DelveInsight's analysis, The growth in demand for injectable drug delivery devices is largely driven by the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders, the increasing adoption of self-injectors, expansion of the biologics and biosimilars market, the growing emphasis on patient compliance with treatments, and continuous innovations and technological advancements in the field.

DelveInsight's "Injectable Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Injectable Drug Delivery Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Injectable Drug Delivery Devices market, get a snapshot of the report Injectable Drug Delivery Devices Market Trends
https://www.delveinsight.com/sample-request/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Injectable Drug Delivery Devices Overview
Injectable Drug Delivery Devices are medical tools designed to administer medications directly into the body through the skin, muscles, or veins. These devices include syringes, auto-injectors, prefilled syringes, and pen injectors, which ensure accurate dosing, ease of use, and improved patient compliance. They are commonly used for vaccines, insulin, biologics, and other therapies that require rapid or controlled delivery. Modern injectable devices often incorporate safety features, ergonomic designs, and sometimes digital connectivity to enhance patient monitoring and reduce the risk of errors or needle-stick injuries.

DelveInsight Analysis: The injectable drug delivery devices market was valued at USD 19.63 billion in 2023 and is projected to grow at a CAGR of 11.26% from 2024 to 2030, reaching approximately USD 37.22 billion by 2030.

Injectable Drug Delivery Devices Market Insights
Geographically, North America is anticipated to hold the largest share of the Injectable Drug Delivery Devices market, driven by the growing prevalence of chronic diseases, ongoing research and development activities, supportive government initiatives aimed at raising awareness of chronic conditions, and increased healthcare spending, all of which are expected to significantly contribute to market growth during the forecast period.

To read more about the latest highlights related to Injectable Drug Delivery Devices, get a snapshot of the key highlights entailed in the Injectable Drug Delivery Devices
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Injectable Drug Delivery Devices Market Report
• In November 2024, Simulations Plus, Inc. reported receiving a grant from the U.S. FDA to utilize physiologically based pharmacokinetic (PBPK) approaches in GastroPlus® for developing and validating mechanistic in vitro-in vivo correlations (IVIVCs) for long-acting injectable (LAI) technologies. This initiative is being carried out in collaboration with the University of Connecticut's School of Pharmacy, Department of Pharmaceutical Sciences.
• In August 2022, Zydus Cadila's needle-free plasmid DNA COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI).
• Thus, owing to such developments in the market, rapid growth will be observed in the Injectable Drug Delivery Devices market during the forecast period

Key Players in the Injectable Drug Delivery Devices Market
Some of the key market players operating in the Injectable Drug Delivery Devices market include- Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Inc., Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc., Mylan N.V., Vetter Pharma-Fertigung GmbH & Co.KG, and others.

Which MedTech key players in the Injectable Drug Delivery Devices market are set to emerge as the trendsetter explore @ Key Injectable Drug Delivery Devices Companies
https://www.delveinsight.com/sample-request/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Injectable Drug Delivery Devices Market Landscape
Advancements in technology have significantly boosted patient acceptance of self-injectors. For example, the use of liquefied gas, such as hydrofluoroalkane (HFA), as a power source provides key benefits over traditional spring-based injectors. Unlike springs, HFA-powered autoinjectors deliver a constant force throughout the injection, requiring lower peak forces to complete delivery. This reduces stress on the syringe and minimizes force variation during drug administration.

As a result, the advantages offered by self-injectors compared to other delivery devices are driving higher patient preference, ultimately fueling growth in the self-injector market.

Scope of the Injectable Drug Delivery Devices Market Report
• Coverage: Global
• Study Period: 2021-2030
• Injectable Drug Delivery Devices Market Segmentation By Product Type: Self-Injectors, Needle-Free, Auto-Injectors, Wearable Injectors, and Insulin Pens
• Injectable Drug Delivery Devices Market Segmentation By Drug Loading: Prefilled Injection Devices and Fillable Injection Devices
• Injectable Drug Delivery Devices Market Segmentation By Reusability: Reusable and Disposable
• Injectable Drug Delivery Devices Market Segmentation By Site of Delivery: Intramuscular, Subcutaneous, and Intra Dermal
• Injectable Drug Delivery Devices Market Segmentation By Application: Injectable Drug Delivery Devices Market Segmentation By End User: Hospital & Retail Pharmacy, E-Commerce, and others
• Injectable Drug Delivery Devices Market Segmentation By End User: Hospitals, Specialty Clinics, and Homecare Settings
• Injectable Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Injectable Drug Delivery Devices Companies: Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Inc., Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc., Mylan N.V., Vetter Pharma-Fertigung GmbH & Co.KG, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Injectable Drug Delivery Devices market will grow by 2030? Click to get a snapshot of the Injectable Drug Delivery Devices Market Analysis
https://www.delveinsight.com/sample-request/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.